COVID-19 update: at this moment there are no interruptions to Dexcom’s ability to produce
and supply product as a result of the Coronavirus. Please click here for more information.
For Technical Support, please click here to submit a request form.
Click here for information regarding the use of Dexcom CGM in Hospitals during COVID-19.
X
Continuous Glucose Monitoring (CGM) is a method to track glucose levels throughout the day and night.
Learn More
Blood Glucose Meters (BGM) measure glucose levels at a single moment in time, while Continuous Glucose Monitoring (CGM) systems continually check glucose levels throughout the day and night.
Learn More
Unlike a blood glucose meter (BGM), which provides just a single glucose reading. CGM systems can provide real-time, dynamic glucose information every five minutes.
Learn More
At Dexcom, our customers are our heroes - read our Warrior stories to learn more.
Read Stories
Apply today and share your story with us by providing some information about yourself and your experience with Dexcom.
Apply Today
Always know your glucose number and where it's headed with the Dexcom G6 Continuous Glucose Monitoring (CGM) System - FDA-permitted for making diabetes treatment decisions with zero fingersticks and no calibration.*
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
See your glucose number in real time with just a quick glance at your smart device with Dexcom G6.†
Always know your glucose number and where it's headed with zero fingersticks and no calibration* — with the new Dexcom G6.
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
The Dexcom G6 features a 10-day wear sensor that is designed to be water-resistant and easy-to-insert‡ with an auto-applicator.
Dexcom CGM is proven to lower A1C and reduce hypoglycemic incidents§, and it helps you see where your glucose levels are heading.
The Dexcom G6 is FDA-permitted to make diabetes treatment decisions without confirmatory fingersticks or calibration.*
* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Always know your glucose numbers with just a quick glance at your smart device. Set your range to get notified when you’re heading too high or low.
Use the Dexcom Share feature available in the Dexcom G6 CGM app to provide your glucose data with up to 10 followers.††
Managing diabetes can be complex. With Dexcom CLARITY Reporting Software, diabetes data reporting and management are now made simple.
Dexcom is committed to helping patients have a positive CGM experience and better diabetes management. From help getting started, to tutorials and FAQs, Dexcom can provide support and guidance for a better experience with Continuous Glucose Monitoring (CGM).
Are you new to the Dexcom CGM System? Our Dexcom CARE team can help you get started for the first time with your new system.
Our technical support team is available 24 hours a day; 7 days a week to help you with any technical issues that may arise.
The Dexcom G6 is covered by most insurance plans. Getting started is simple, just provide a few details and we'll contact you to begin your order.
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
|| Data on file.
† For a list of compatible devices, visit www.dexcom.com/compatibility.
‡ The Dexcom G6 Sensor and Transmitter are water-resistant and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.
§ The urgent low soon can warn you in advance of severe hypoglycemia—allowing you time to take appropriate action before it happens.
†† Separate Follow app required.
1 Dexcom G6 CGM System User Guide, 2018.
2 JAMA. 2017;317(4):371-378.
3 Welsh, J.B. et al (2019). "Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems." Diabetes Technol Ther 21(3) Dexcom, Dexcom G6, Dexcom Share, and Dexcom CLARITY are registered trademarks of Dexcom, Inc. in the United States and/or other countries.
BRIEF SAFETY STATEMENT Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
The web-based Dexcom CLARITY® software is intended for use by both home users and healthcare professionals to assist people with diabetes in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them.
